Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hadi Mostafaei

Showing results (41-50 of 132) with videos related to

Pageof 14
Sort By:
International Journal of Clinical Oncology|July 19, 2020
Prognostic value of testosterone for the castration-resistant prostate cancer patients: a systematic review and meta-analysisNoriyoshi Miura, Keiichiro Mori, Hadi Mostafaei, et al.
Arab Journal of Urology|December 14, 2020
The significance of De Ritis ratio in patients with radiation-recurrent prostate cancer undergoing salvage radical prostatectomyFahad Quhal, Mohammad Abufaraj, Florian Janisch, et al.
Prostate Cancer and Prostatic Diseases|March 11, 2020
Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysisKeiichiro Mori, Noriyoshi Miura, Hadi Mostafaei, et al.
Urologic Oncology|July 14, 2020
Low compliance to guidelines in nonmuscle-invasive bladder carcinoma: A systematic reviewKeiichiro Mori, Noriyoshi Miura, Marek Babjuk, et al.
Cancer Treatment Reviews|June 21, 2021
Differences in oncological and toxicity outcomes between programmed cell death-1 and programmed cell death ligand-1 inhibitors in metastatic renal cell carcinoma: A systematic review and meta-analysisKeiichiro Mori, Benjamin Pradere, Fahad Quhal, et al.
Clinical Genitourinary Cancer|September 28, 2019
Prognostic Value of Lactate Dehydrogenase in Metastatic Prostate Cancer: A Systematic Review and Meta-analysisKeiichiro Mori, Shoji Kimura, Mehdi Kardoust Parizi, et al.
Neurourology and Urodynamics|January 15, 2022
Efficacy of percutaneous and transcutaneous posterior tibial nerve stimulation on idiopathic overactive bladder and interstitial cystitis/painful bladder syndrome: A systematic review and meta-analysisAmirhossein Ghavidel-Sardsahra, Morteza Ghojazadeh, Mohammad Sajjad Rahnama'I, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|June 19, 2020
Metastasis-directed therapy and prostate-targeted therapy in oligometastatic prostate cancer: a systematic reviewNoriyoshi Miura, Benjamin Pradere, Keiichiro Mori, et al.
International Journal of Clinical Oncology|September 14, 2020
Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysisKeiichiro Mori, Hadi Mostafaei, Benjamin Pradere, et al.
Turkish Journal of Urology|October 14, 2020
Diagnostic challenges and treatment strategies in the management of upper-tract urothelial carcinomaVictor M Schuettfort, Benjamin Pradere, Fahad Quhal, et al.
Pageof 14

Showing results (41-50 of 132) with videos related to

Sort By:
Pageof 14
International Journal of Clinical Oncology|July 19, 2020
Prognostic value of testosterone for the castration-resistant prostate cancer patients: a systematic review and meta-analysisNoriyoshi Miura, Keiichiro Mori, Hadi Mostafaei, et al.
Arab Journal of Urology|December 14, 2020
The significance of De Ritis ratio in patients with radiation-recurrent prostate cancer undergoing salvage radical prostatectomyFahad Quhal, Mohammad Abufaraj, Florian Janisch, et al.
Prostate Cancer and Prostatic Diseases|March 11, 2020
Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysisKeiichiro Mori, Noriyoshi Miura, Hadi Mostafaei, et al.
Urologic Oncology|July 14, 2020
Low compliance to guidelines in nonmuscle-invasive bladder carcinoma: A systematic reviewKeiichiro Mori, Noriyoshi Miura, Marek Babjuk, et al.
Cancer Treatment Reviews|June 21, 2021
Differences in oncological and toxicity outcomes between programmed cell death-1 and programmed cell death ligand-1 inhibitors in metastatic renal cell carcinoma: A systematic review and meta-analysisKeiichiro Mori, Benjamin Pradere, Fahad Quhal, et al.
Clinical Genitourinary Cancer|September 28, 2019
Prognostic Value of Lactate Dehydrogenase in Metastatic Prostate Cancer: A Systematic Review and Meta-analysisKeiichiro Mori, Shoji Kimura, Mehdi Kardoust Parizi, et al.
Neurourology and Urodynamics|January 15, 2022
Efficacy of percutaneous and transcutaneous posterior tibial nerve stimulation on idiopathic overactive bladder and interstitial cystitis/painful bladder syndrome: A systematic review and meta-analysisAmirhossein Ghavidel-Sardsahra, Morteza Ghojazadeh, Mohammad Sajjad Rahnama'I, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|June 19, 2020
Metastasis-directed therapy and prostate-targeted therapy in oligometastatic prostate cancer: a systematic reviewNoriyoshi Miura, Benjamin Pradere, Keiichiro Mori, et al.
International Journal of Clinical Oncology|September 14, 2020
Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysisKeiichiro Mori, Hadi Mostafaei, Benjamin Pradere, et al.
Turkish Journal of Urology|October 14, 2020
Diagnostic challenges and treatment strategies in the management of upper-tract urothelial carcinomaVictor M Schuettfort, Benjamin Pradere, Fahad Quhal, et al.
Pageof 14